Brown Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,216
Closed -$248K 124
2018
Q3
$248K Sell
3,216
-949
-23% -$71.7K ﹤0.01% 122
2018
Q2
$295K Sell
4,165
-694
-14% -$49K ﹤0.01% 121
2018
Q1
$366K Sell
4,859
-3,549
-42% -$282K ﹤0.01% 120
2017
Q4
$602K Sell
8,408
-806
-9% -$61.2K 0.01% 106
2017
Q3
$747K Sell
9,214
-864
-9% -$66.1K 0.01% 92
2017
Q2
$713K Buy
10,078
+103
+1% +$6.85K 0.01% 95
2017
Q1
$678K Sell
9,975
-5,774
-37% -$406K 0.01% 101
2016
Q4
$1.13M Sell
15,749
-18,564
-54% -$1.38M 0.02% 77
2016
Q3
$2.71M Sell
34,313
-1,830
-5% -$149K 0.04% 84
2016
Q2
$3.02M Sell
36,143
-51,284
-59% -$4.55M 0.05% 86
2016
Q1
$8.03M Sell
87,427
-6,970
-7% -$629K 0.13% 56
2015
Q4
$9.55M Buy
94,397
+3,189
+3% +$332K 0.15% 60
2015
Q3
$8.96M Buy
91,208
+18,803
+26% +$2.09M 0.15% 62
2015
Q2
$8.48M Buy
72,405
+1,074
+2% +$117K 0.14% 70
2015
Q1
$7M Sell
71,331
-150
-0.2% -$15.2K 0.12% 76
2014
Q4
$6.74M Sell
71,481
-12,644
-15% -$1.31M 0.12% 79
2014
Q3
$8.96M Sell
84,125
-20,847
-20% -$2.04M 0.16% 67
2014
Q2
$8.7M Buy
104,972
+1,243
+1% +$96.8K 0.14% 75
2014
Q1
$7.35M Sell
103,729
-17
-0% -$1.33K 0.12% 74
2013
Q4
$7.8M Sell
103,746
-6,733
-6% -$469K 0.13% 73
2013
Q3
$6.94M Sell
110,479
-109
-0.1% -$6.51K 0.12% 73
2013
Q2
$5.66M Buy
+110,588
New +$5.76M 0.12% 76

Other funds holding GILD

Brown Capital Management's GILD Position: Q4 2018 in Review

Brown Capital Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,216 shares — an estimated $248K sold.

Brown Capital Management first reported a position in GILD in Q2 2013 and held it in 22 quarters. The position peaked at $9.55M in Q4 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Brown Capital Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Brown Capital Management sold 3,216 Gilead Sciences shares in Q4 2018, an estimated $248K.
  • Brown Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 22 quarters.
  • Brown Capital Management's Gilead Sciences position peaked at $9.55M in Q4 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Brown Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.